Related Experiment Video
Updated: May 23, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Condensates as a Culprit in RAS Activation and Inhibitor Resistance.
Hannah C Bergo1,2,3, Logan B Leak1,2,3, Trever G Bivona1,2,3,4
1Department of Medicine, University of California, San Francisco, San Francisco, California.
ARAF protein forms novel condensates that sustain RAS signaling, driving therapy resistance in cancers. Targeting these ARAF-RAS condensates may overcome resistance to RAS-targeted treatments.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Therapy resistance is a major cause of mortality in oncogene-driven cancers.
- Understanding resistance mechanisms is crucial for developing effective cancer treatments.
Purpose of the Study:
- To elucidate a novel resistance mechanism in targeted cancer therapy.
- To investigate the role of ARAF in RAS-mediated signaling and therapy resistance.
Main Methods:
- Investigated the function of ARAF in RAS signaling.
- Utilized techniques to study protein interactions and localization.
- Examined the role of ARAF in phase-separated condensates.
Main Results:
- ARAF sequesters active RAS in phase-separated condensates at the plasma membrane.
- This sequestration sustains MAPK pathway signaling and prevents RAS inactivation by neurofibromin 1.
- ARAF exhibits a distinct biological role compared to other RAF proteins.
Conclusions:
- ARAF plays a novel role in sustaining RAS signaling through biomolecular condensates.
- This mechanism contributes to therapy resistance in RAS-driven cancers.
- Targeting ARAF-mediated condensates presents a potential strategy to overcome treatment resistance.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
MAPK Signaling Cascades
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...